Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Decreased ex vivo production of interferon-gamma is associated with severity and poor prognosis in patients with lupus

Fig. 3

Comparison of poor hospitalisation outcomes according to ex vivo IFN-γ production. The proportion of patients with poor hospitalisation outcomes was larger among patients with ex vivo IFN-γ production ≤ 0.40 IU/mL than in those with ex vivo IFN-γ production > 0.40 IU/mL. Poor hospitalisation outcome was defined as in-hospital mortality and/or intensive care unit admission. IFN-γ interferon gamma

Back to article page